Literature DB >> 12414789

The production of 53-55-kDa isoforms is not required for rat L-histidine decarboxylase activity.

John V Fleming1, Timothy C Wang.   

Abstract

Post-translational processing of the histamine-producing enzyme, L-histidine decarboxylase (HDC), leads to the formation of multiple carboxyl-truncated isoforms. Nevertheless, it has been widely reported that the mature catalytically active dimer is dependent specifically on the production of carboxyl-truncated 53-55-kDa monomers. Here we use transiently transfected COS-7 cells to study the properties of carboxyl-truncated rat HDC isoforms in the 52-58-kDa size range. Amino acid sequences important for the production of a 55-kDa HDC isoform were identified by successive truncations through amino acids 502, 503, and 504. Mutating this sequence in the full-length protein prevented the production of 55-kDa HDC but did not affect enzymatic activity. Further truncations to amino acid 472 generated an inactive 53-kDa HDC isoform that was degraded by the proteasome pathway. These results suggested that processed isoforms, apart from 53-55-kDa ones, contribute toward histamine biosynthesis in vivo. This was confirmed in physiological studies where regulated increases in HDC activity were associated with the expression of isoforms that were greater than 55 kDa in size. We provide evidence to show that regulation of HDC expression can be achieved by the differential production or differential stabilization of multiple enzyme isoforms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414789     DOI: 10.1074/jbc.M210718200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  L-histidine decarboxylase and Tourette's syndrome.

Authors:  A Gulhan Ercan-Sencicek; Althea A Stillman; Ananda K Ghosh; Kaya Bilguvar; Brian J O'Roak; Christopher E Mason; Thomas Abbott; Abha Gupta; Robert A King; David L Pauls; Jay A Tischfield; Gary A Heiman; Harvey S Singer; Donald L Gilbert; Pieter J Hoekstra; Thomas M Morgan; Erin Loring; Katsuhito Yasuno; Thomas Fernandez; Stephan Sanders; Angeliki Louvi; Judy H Cho; Shrikant Mane; Christopher M Colangelo; Thomas Biederer; Richard P Lifton; Murat Gunel; Matthew W State
Journal:  N Engl J Med       Date:  2010-05-05       Impact factor: 91.245

Review 2.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

3.  The C-terminus of rat L-histidine decarboxylase specifically inhibits enzymic activity and disrupts pyridoxal phosphate-dependent interactions with L-histidine substrate analogues.

Authors:  John V Fleming; Ignacio Fajardo; Michael R Langlois; Francisca Sánchez-Jiménez; Timothy C Wang
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

4.  Mapping of catalytically important residues in the rat L-histidine decarboxylase enzyme using bioinformatic and site-directed mutagenesis approaches.

Authors:  John V Fleming; Francisca Sánchez-Jiménez; Aurelio A Moya-García; Michael R Langlois; Timothy C Wang
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.